Crowell & Moring Bolsters Antitrust Capabilities with Senior Of Counsel Professor Andrew I. Gavil
Firm News | 2 min read | 07.12.16
Washington, D.C. – July 12, 2016: Crowell & Moring is pleased to announce that Andrew I. Gavil, a former office director at the Federal Trade Commission (FTC) and a leading academic authority on antitrust law, has joined its Antitrust Group in Washington, D.C. as senior of counsel.
Gavil, a former director of the FTC’s Office of Policy Planning, is a Professor of Law at the Howard University School of Law, a position he has held since 1989. He teaches courses on antitrust law, federal regulation, civil procedure, and complex litigation. He has written, lectured, and commented extensively in the U.S. and abroad on antitrust law, jurisdiction, and procedure. His experience extends to many aspects of antitrust law, litigation, and competition policy, including the litigation of complex antitrust claims and defenses, exclusionary conduct by dominant firms, the analysis of theories of competitive harm, regulatory responses to new and disruptive firms and business models, and international and comparative aspects of competition law.
“We are excited to have Andy join our firm,” said Wm. Randolph Smith, chair of Crowell & Moring’s Antitrust Group. “His vast knowledge of complex antitrust issues, both from the academic world and from his experience at the FTC, brings an unparalleled perspective for our clients and will further enhance our regulatory and litigation capabilities.”
Additionally, Gavil has co-authored several books, including a leading antitrust casebook and Microsoft and the Globalization of Antitrust Law: Competition Policy for the Twenty-First Century. He has also been recognized by the Section of Antitrust Law of the American Bar Association for his contributions to the work of the section, and is the incoming Chair of the Editorial Board of the Antitrust Law Journal and the Chair of the Section’s International Scholar in Residence Selection Committee.
Gavil will remain a professor at Howard while working at Crowell & Moring. He earned his J.D. from Northwestern University School of Law, where he was a member of the Law Review, and earned his B.A. magna cum laude from Queens College of the City University of New York.
Crowell & Moring's Antitrust Group is highly respected in the United States and around the world. Our lawyers routinely represent industry-leading companies in some of the largest and most complex mergers and acquisitions in recent history, as well as in both affirmative recovery and defense-side antitrust litigation. Clients engage us to help navigate their most complex competition law issues, including: international merger control; private damages actions; cartel investigations and litigation; government investigations; and counseling and compliance.
Crowell & Moring LLP is an international law firm with approximately 500 lawyers representing clients in litigation and arbitration, regulatory, and transactional matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation, as well as its ongoing commitment to pro bono service and diversity. The firm has offices in Washington, DC, New York, Los Angeles, San Francisco, Orange County, Anchorage, London, and Brussels.
Insights
Firm News | 1 min read | 03.11.25
Crowell & Moring Represents Nuclear Energy Startup Atomic Alchemy in its Acquisition by Oklo
March 11, 2025: Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced on March 5, 2025 that it has closed the $25 million acquisition of Crowell client Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Oklo intends to use this strategic acquisition to establish a more reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Demand for radioisotopes is expected to increase significantly over the next decade, while global supply struggles to keep pace due to aging reactor infrastructure and a fragmented global supply chain, which at present is dominated by countries outside the United States. Atomic Alchemy intends to be a low-cost U.S. radioisotope producer that can provide a secure and domestic supply of radioisotopes to U.S. companies commercializing innovative radioisotope applications. With its proprietary VIPR® technology, Atomic Alchemy is building the first scalable production facility to provide a reliable, sustainable source of high-value radioisotopes. Using a vertically integrated model and fuel recycling, in partnership with Oklo, Atomic Alchemy is transforming isotope production to address global shortages, support critical applications, and strengthen national security. The core deal team included Samuel Holland Edwards, Jon O’Connell, Justin Lurie, and Ryan Flynn.
Firm News | 2 min read | 03.11.25
Daily Journal Honors Crowell & Moring Victory in University of California Case
Firm News | 2 min read | 03.11.25
Foreign Investment Watch Names Caroline Brown a Top Advisor 2025
Firm News | 2 min read | 03.07.25
Crowell & Moring Attorneys Honored With 2025 Burton Award for Distinguished Legal Writing